HTHa Thi Thu Tran

Ha Thi Thu Tran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ha Thi Thu Tran has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Hung Van Nguyen

    Affiliations Rheumatology Center, Bach Mai Hospital, Hanoi, Vietnam, Internal Medicine Department, Hanoi Medical University, Hanoi, Vietnam

    2 shared publications
  • Thi Hoa Nguyen

    Affiliations Department of Psychiatry, Hanoi Medical University, Hanoi, Vietnam, National Institute of Mental Health, Hanoi, Vietnam

    2 shared publications
  • An Thi Ha Tran

    Affiliations Department of Psychiatry, Hanoi Medical University, Hanoi, Vietnam, National Institute of Mental Health, Hanoi, Vietnam

    1 shared publication
  • Ban N. Ha

    Heart Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam

    1 shared publication
  • Cam Vu

    Vietnam National Institute of Mental Health Hanoi Vietnam

    1 shared publication
  • Duong Lai

    Vietnam National Institute of Mental Health Hanoi Vietnam

    1 shared publication

Latest Publications

  • Open Access

    Suicidal ideation and interrelated psychiatric disturbances in rheumatoid arthritis: Evidence from a Vietnamese cohort

    by Ha Thi Thu Tran, Tam Minh Duong, Tuan Van Nguyen, Ha Thi Thu Le, Hue Thi Doan, Yen Hoang Nguyen, Hoa Thi Nguyen, Long Thanh Nguyen, Thang Xuan Pham, An Thi Ha Tran, et al.

    Objective: This study aimed to determine the prevalence of suicidal ideation among Vietnamese patients with rheumatoid arthritis (RA), and to examine associated factors, other psychiatric disturbances, and quality of life (QoL). Methods: A cross-sectional study was conducted from June 2024 to December 2024 at Bach Mai Hospital, Hanoi. Eligible patients met the 1987 ACR classification criteria for RA. Suicidal ideation was assessed through structured psychiatric interviews. Depression, anxiety, insomnia, and sexual dysfunction were evaluated using the PHQ-9, HAM-A, ISI, and ASEX, respectively, while QoL was measured with the EQ-5D-5L. Correlation analyses and structural equation modeling (SEM) explored interrelationships among psychiatric disturbances. Multivariable regression was applied to identify predictors of suicidal ideation, psychiatric symptoms, and QoL. Results: Among 187 participants (mean age 56.9 ± 12.7 years; 84.0% female), 13.4% reported suicidal ideation. Anxious (45.5%), insomnia (48.1%) and depressive symptoms (28.3%) were highly common, and depressive, anxiety, and insomnia symptoms were strongly interrelated (e.g., r = 0.74–0.80). The mean EQ-5D-5L index value was 0.6 ± 0.2, indicating moderate impairment in overall QoL. SEM confirmed high correlation between psychiatric (DEP, ANX) and behavioral (SLP, SEX) disturbances. Multivariable analysis showed that high disease activity, joint deformity, and treatment-related adverse effects were consistently associated with suicidal ideation, psychiatric symptoms, and impaired QoL. Conclusion: Suicidal ideation and other psychiatric disturbances are commonly observedamong patients with RA in Vietnam. Disease activity, structural damage, and medication-related adverse effects were major determinants, underscoring the need for integrated mental health screening and multidisciplinary management to optimize both clinical and psychosocial outcomes.

  • Open Access

    Validation of the Vietnamese version of the Montgomery-Asberg depression rating scale (MADRS) in rheumatoid arthritis patients

    by Ha Tran, Long Hoang, Hung Van Nguyen, Tuan Van Nguyen, Ha Le, Yen Nguyen, Hoa Nguyen, Hue Doan, Khiem Ngo, Thien Le, et al.

    This study aimed to validate the Vietnamese version of the Montgomery-Asberg Depression Rating Scale (MADRS) in patients with rheumatoid arthritis (RA). A cross-sectional study was conducted on RA patients, with depression severity assessed using both MADRS and the Patient Health Questionnaire-9 (PHQ-9). Internal consistency was evaluated using Cronbach’s alpha, and the correlation between MADRS and PHQ-9 was measured using Spearman’s correlation. Face validity was established through a back-translation process to ensure language equivalence. The translated version underwent exploratory and confirmatory factor analysis to evaluate its construct validity. The Vietnamese MADRS demonstrated excellent internal consistency (Cronbach’s alpha = 0.93) and a strong linear correlation with PHQ-9 (Spearman’s r = 0.88). Exploratory factor analysis identified a two-factor structure, categorizing depressive symptoms into general and severe clusters, which was confirmed in confirmatory factor analysis with borderline goodness of fit. Despite limitations such as sample specificity and the absence of a gold standard diagnostic tool, the study suggests that the Vietnamese MADRS can be effectively used in clinical and research settings in Vietnam for assessing depression in RA patients.


  • Open Access

    Pharmacist-Led Intervention to Enhance Medication Adherence in Patients With Acute Coronary Syndrome in Vietnam: A Randomized Controlled Trial

    by Thang Nguyen, Thao H. Nguyen, Phu T. Nguyen, Ha T. Tran, Ngoc V. Nguyen, Hoa Q. Nguyen, Ban N. Ha, Tam T. Pham, Katja Taxis

    Background: Patient adherence to cardioprotective medications improves outcomes of acute coronary syndrome (ACS), but few adherence-enhancing interventions have been tested in low-income and middle-income countries. Objectives: We aimed to assess whether a pharmacist-led intervention enhances medication adherence in patients with ACS and reduces mortality and hospital readmission. Methods: We conducted a randomized controlled trial in Vietnam. Patients with ACS were recruited, randomized to the intervention or usual care prior to discharge, and followed 3 months after discharge. Intervention patients received educational and behavioral interventions by a pharmacist. Primary outcome was the proportion of adherent patients 1 month after discharge. Adherence was a combined measure of self-reported adherence (the 8–item Morisky Medication Adherence Scale) and obtaining repeat prescriptions on time. Secondary outcomes were (1) the proportion of patients adherent to medication; (2) rates of mortality and hospital readmission; and (3) change in quality of life from baseline assessed with the European Quality of Life Questionnaire – 5 Dimensions – 3 Levels at 3 months after discharge. Logistic regression was used to analyze data. Registration: ClinicalTrials.gov (NCT02787941). Results: Overall, 166 patients (87 control, 79 intervention) were included (mean age 61.2 years, 73% male). In the analysis excluding patients from the intervention group who did not receive the intervention and excluding all patients who withdrew, were lost to follow-up, died or were readmitted to hospital, a greater proportion of patients were adherent in the intervention compared with the control at 1 month (90.0% vs. 76.5%; adjusted OR = 2.77; 95% CI, 1.01–7.62) and at 3 months after discharge (90.2% vs. 77.0%; adjusted OR = 3.68; 95% CI, 1.14–11.88). There was no significant difference in median change of EQ-5D-3L index values between intervention and control [0.000 (0.000; 0.275) vs. 0.234 (0.000; 0.379); p = 0.081]. Rates of mortality, readmission, or both were 0.8, 10.3, or 11.1%, respectively; with no significant differences between the 2 groups. Conclusion: Pharmacist-led interventions increased patient adherence to medication regimens by over 13% in the first 3 months after ACS hospital discharge, but not quality of life, mortality and readmission. These results are promising but should be tested in other settings prior to broader dissemination.